Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000071.xml
Semin Neurol 2010; 30(4): 337-349
DOI: 10.1055/s-0030-1267277
© Thieme Medical Publishers
DOI: 10.1055/s-0030-1267277
Laboratory Evaluation of Peripheral Neuropathy
Further Information
Publication History
Publication Date:
12 October 2010 (online)
ABSTRACT
Laboratory testing to help determine the cause of a peripheral neuropathy can be challenging. A rational approach, as opposed to a shotgun approach, is advocated for efficiency and expense. The author reviews a spectrum of tests and provides a basis for when to order and not to order.
KEYWORDS
Neuropathy - laboratory testing
REFERENCES
- 1 Martyn C N, Hughes R AC. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997; 62(4) 310-318
- 2 Dyck P J, Oviatt K F, Lambert E H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol. 1981; 10(3) 222-226
- 3 Barohn R J. Approach to peripheral neuropathy and neuronopathy. Semin Neurol. 1998; 18(1) 7-18
- 4 England J D, Gronseth G S, Franklin G et al.. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009; 72(2) 185-192
- 5 Smith A G, Singleton J R. The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med. 2004; 164(9) 1021-1025
- 6 Smith A G, Rose K, Singleton J R. Idiopathic neuropathy patients are at high risk for metabolic syndrome. J Neurol Sci. 2008; 273(1-2) 25-28
- 7 Nemni R, Bottacchi E, Fazio R et al.. Polyneuropathy in hypothyroidism: clinical, electrophysiological and morphological findings in four cases. J Neurol Neurosurg Psychiatry. 1987; 50(11) 1454-1460
- 8 Rao S N, Katiyar B C, Nair K R, Misra S. Neuromuscular status in hypothyroidism. Acta Neurol Scand. 1980; 61(3) 067-177
- 9 Duyff R F, Van den Bosch J, Laman D M, van Loon B JP, Linssen W HJ. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry. 2000; 68(6) 750-755
- 10 Kececi H, Degirmenci Y. Hormone replacement therapy in hypothyroidism and nerve conduction study. Neurophysiol Clin. 2006; 36(2) 79-83
- 11 Penza P, Lombardi R, Camozzi F, Ciano C, Lauria G. Painful neuropathy in subclinical hypothyroidism: clinical and neuropathological recovery after hormone replacement therapy. Neurol Sci. 2009; 30(2) 149-151
- 12 Lubec D, Müllbacher W, Finsterer J, Mamoli B. Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases. Postgrad Med J. 1999; 75(890) 723-727
- 13 Burn D J, Bates D. Neurology and the kidney. J Neurol Neurosurg Psychiatry. 1998; 65(6) 810-821
- 14 Brouns R, De Deyn P P. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004; 107(1) 1-06
- 15 Manzoor M, Runcie J. Folate-responsive neuropathy: report of 10 cases. BMJ. 1976; 1(6019) 1176-1178
- 16 Kumar N. Neurological manifestations of systemic disease. CONTINUUM: Lifelong Learning in Neurology. 2008; 14(1) 13-52
- 17 Schaumburg H, Kaplan J, Windebank A et al.. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med. 1983; 309(8) 445-448
- 18 Berger A, Schaumburg H H. More on neuropathy from pyridoxine abuse. N Engl J Med. 1984; 311(15) 986-987
- 19 Parry G J, Bredesen D E. Sensory neuropathy with low-dose pyridoxine. Neurology. 1985; 35(10) 1466-1468
- 20 Bernstein A L. Vitamin B6 in clinical neurology. Ann N Y Acad Sci. 1990; 585 250-260
- 21 Kumar N, Gross Jr J B, Ahlskog J E. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology. 2004; 63(1) 33-39
- 22 Nations S P, Boyer P J, Love L A et al.. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology. 2008; 71(9) 639-643
- 23 Rowin J, Lewis S L. Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation. J Neurol Neurosurg Psychiatry. 2005; 76(5) 750-751
- 24 Lewis S L. Neurological complications of Sjogren syndrome and rheumatoid arthritis. CONTINUUM: Lifelong Learning in Neurology. 2008; 14(1) 120-144
- 25 Mori K, Iijima M, Koike H et al.. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain. 2005; 128(Pt 11) 2518-2534
- 26 Gøransson L G, Herigstad A, Tjensvoll A B, Harboe E, Mellgren S I, Omdal R. Peripheral neuropathy in primary Sjogren syndrome: a population-based study. Arch Neurol. 2006; 63(11) 0612-0615
- 27 Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol. 2005; 252(6) 633-641
- 28 Pagnoux C, Guillevin L. Peripheral neuropathy in systemic vasculitides. Curr Opin Rheumatol. 2005; 17(1) 41-48
- 29 Bouche P, Léger J M, Travers M A, Cathala H P, Castaigne P. Peripheral neuropathy in systemic vasculitis: clinical and electrophysiologic study of 22 patients. Neurology. 1986; 36(12) 1598-0602
- 30 Castaigne P, Brunet P, Hauw J J, Léger J M, Gherardi R, Guillevin L. [Peripheral nervous system and panarteritis nodosa. Review of 27 cases]. Rev Neurol (Paris). 1984; 140(5) 343-352
- 31 Said G. Necrotizing peripheral nerve vasculitis. Neurol Clin. 1997; 15(4) 835-848
- 32 Chin R L, Sander H W, Brannagan T H et al.. Celiac neuropathy. Neurology. 2003; 60(10) 1581-1585
- 33 Rosenberg N R, Vermeulen M. Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy?. J Neurol Neurosurg Psychiatry. 2005; 76(10) 1415-1419
- 34 Brannagan III T H, Hays A P, Chin S S et al.. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch Neurol. 2005; 62(10) 1574-1578
- 35 Rudnicki S A, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol. 2005; 18(5) 598-603
- 36 Antoine J C, Honnorat J, Camdessanché J P et al.. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol. 2001; 49(2) 214-221
- 37 Kelly J J, Kyle R A, O'Brien P C, Dyke P J. Prevalence of monoclonal protein in peripheral neuropathy. Neurology. 1981; 31 1480-1483
- 38 Kahn S N, Bina M. Sensitivity of immunofixation electrophoresis for detecting IgM paraproteins in serum. Clin Chem. 1988; 34(8) 0633-0635
- 39 Kyle R A, Therneau T M, Rajkumar S V et al.. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006; 354(13) 1362-1369
- 40 Kyle R A, Therneau T M, Rajkumar S V et al.. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002; 346(8) 564-569
- 41 Dispenzieri A, Kyle R, Merlini G et al.. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia. 2009; 23 215-224
- 42 Ramchandren S, Lewis R A. Monoclonal gammopathy and neuropathy. Curr Opin Neurol. 2009; 22(5) 480-485
- 43 Simmons Z, Blaivas M, Aguilera A J, Feldman E L, Bromberg M B, Towfighi J. Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis. J Neurol Sci. 1993; 120(1) 60-63
- 44 Kelly Jr J J, Kyle R A, Miles J M, Dyck P J. Osteosclerotic myeloma and peripheral neuropathy. Neurology. 1983; 33(2) 202-210
- 45 Latov N, Sherman W H, Nemni R et al.. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med. 1980; 303(11) 618-621
- 46 Kissel J T. Autoantibody testing in the evaluation of peripheral neuropathy. Semin Neurol. 1998; 18(1) 83-94
- 47 Pestronk A, Li F, Griffin J et al.. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology. 1991; 41(3) 357-362
- 48 Kornberg A J, Pestronk A. Antibody-associated polyneuropathy syndromes: principles and treatment. Semin Neurol. 2003; 23(2) 181-190
- 49 Notermans N C, Wokke J HJ, van den Berg L H et al.. Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy. Brain. 1996; 119(Pt 2) 421-427
- 50 Wolfe G I, El-Feky W H, Katz J S, Bryan W W, Wians Jr F H, Barohn R J. Antibody panels in idiopathic polyneuropathy and motor neuron disease. Muscle Nerve. 1997; 20(10) 1275-1283
- 51 Periquet I, Kissel J, Collins M et al.. A prospective study of painful sensory neuropathies. Neurology. 1997; 48 A186-A187
- 52 Pestronk A, Choksi R, Bieser K et al.. Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoprotein. Muscle Nerve. 1994; 17(11) 1293-1300
- 53 Donofrio P D, Wilbourn A J, Albers J W, Rogers L, Salanga V, Greenberg H S. Acute arsenic intoxication presenting as Guillain-Barré-like syndrome. Muscle Nerve. 1987; 10(2) 114-120
- 54 Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry. 2003; 74(9) 1267-1271
- 55 Verma A, Bradley W G. HIV-1 associated neuropathies. CNS Spectr. 2000; 5(5) 66-72
- 56 Said G, Lacroix C, Planté-Bordeneuve V et al.. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain. 2002; 125(Pt 2) 264-275
Mark B BrombergM.D. Ph.D.
Department of Neurology, Clinical Neurosciences Center, University of Utah
175 North Medical Drive, Salt Lake City, UT 84132
Email: mbromberg@hsc.utah.edu